ADVANCED PLEURAL MALIGNANT MESOTHELIOMA
Clinical trials for ADVANCED PLEURAL MALIGNANT MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED PLEURAL MALIGNANT MESOTHELIOMA trials appear
Sign up with your email to follow new studies for ADVANCED PLEURAL MALIGNANT MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat cancers: experimental drug aims to boost chemo power
Disease control OngoingThis study is testing a new oral drug called TRC102 (methoxyamine) to see if it can make standard chemotherapy drugs more effective against advanced solid tumors and mesothelioma. It aims to find the safest dose and see if the combination can shrink tumors in patients whose cance…
Matched conditions: ADVANCED PLEURAL MALIGNANT MESOTHELIOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Scientists test new weapon to attack advanced cancers
Disease control OngoingThis early-stage trial is testing a new drug called BAY 1895344, given alongside standard chemotherapy drugs, in people with advanced solid tumors that have spread. The main goal is to find the safest and most effective dose of this combination. Researchers are especially interes…
Matched conditions: ADVANCED PLEURAL MALIGNANT MESOTHELIOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC